Discovering disease genes by analyzing genetic variations and gene activity.
An integrative approach to disease gene discovery combining genetic variation, gene expression, and epigenetics.
This study is looking at how certain genetic differences can affect age-related macular degeneration, with the goal of finding better ways to understand and treat this eye condition, so patients can have more effective options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11083162 on NIH RePORTER |
What this research studies
This research aims to uncover the biological significance of genetic variations linked to diseases, particularly focusing on age-related macular degeneration. By integrating various types of molecular data, including gene expression and epigenetic information, the study seeks to develop new statistical methods to better understand how these genetic factors contribute to disease. Patients may benefit from improved insights into the genetic basis of their conditions, which could lead to more effective treatments. The research will utilize large datasets from existing studies to enhance the understanding of how genetic variations affect health.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with age-related macular degeneration or those with a family history of related eye diseases.
Not a fit: Patients with non-genetic forms of macular degeneration or those without a genetic predisposition may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise treatments for age-related macular degeneration and other genetic conditions.
How similar studies have performed: Previous research using similar integrative approaches has shown promise in identifying disease-related genetic factors, suggesting potential for success in this study.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Zhou, Wei — Massachusetts General Hospital
- Study coordinator: Zhou, Wei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.